Third-line therapy - a podcast by The Lancet HIV

The Lancet HIV Editor Peter Hayward talks to Beatriz Grinsztejn (Evandro Chagas National Institute of Infectious Diseases, Fiocruz, Rio de Janeiro, Brazil) about ACTG A5288, an international, multiarm trial investigating management of second-line treatment failure

Further episodes of The Lancet HIV in conversation with

Further podcasts by The Lancet HIV

Website of The Lancet HIV